On the 13th of April 2023, the FDA announced their new trial diversity plan, stressing the importance of increased awareness of participant diversity. We offer consulting on how to involve patients in both pre- ongoing and post stages of trials.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
